The commonly used drugs in endocrine therapy for breast cancer include estrogen analogs (tamoxifen, toremifene), ER degraders (fulvestrant), and aromatase inhibitors (letrozole, anastrozole, exemestane). The gene discussed is ESR1; the disease is breast carcinoma.